These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 14706633)

  • 1. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.
    Ho TY; Wu SL; Cheng SE; Wei YC; Huang SP; Hsiang CY
    Biochem Biophys Res Commun; 2004 Jan; 313(4):938-47. PubMed ID: 14706633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
    J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Receptor-binding ability of fragments 260-600 and 397-796 of SARS-associated coronavirus spike protein].
    Wei HY; Wang JW; Ou YJ; Wang YB; Qu JG; Zhao WM; Hong T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):353-7. PubMed ID: 16415994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.
    Song HC; Seo MY; Stadler K; Yoo BJ; Choo QL; Coates SR; Uematsu Y; Harada T; Greer CE; Polo JM; Pileri P; Eickmann M; Rappuoli R; Abrignani S; Houghton M; Han JH
    J Virol; 2004 Oct; 78(19):10328-35. PubMed ID: 15367599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.
    Zhao J; Wang W; Yuan Z; Jia R; Zhao Z; Xu X; Lv P; Zhang Y; Jiang C; Gao XM
    Virology; 2007 Mar; 359(2):362-70. PubMed ID: 17055551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for searching antigenic regions in the SARS-CoV spike protein.
    Ren Y; Zhou Z; Liu J; Lin L; Li S; Wang H; Xia J; Zhao Z; Wen J; Zhou C; Wang J; Yin J; Xu N; Liu S
    Genomics Proteomics Bioinformatics; 2003 Aug; 1(3):207-15. PubMed ID: 15629033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
    Chen J; Miao L; Li JM; Li YY; Zhu QY; Zhou CL; Fang HQ; Chen HP
    World J Gastroenterol; 2005 Oct; 11(39):6159-64. PubMed ID: 16273643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
    Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
    Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
    J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
    Chen Z; Zhang L; Qin C; Ba L; Yi CE; Zhang F; Wei Q; He T; Yu W; Yu J; Gao H; Tu X; Gettie A; Farzan M; Yuen KY; Ho DD
    J Virol; 2005 Mar; 79(5):2678-88. PubMed ID: 15708987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
    Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
    Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein.
    McBride CE; Machamer CE
    J Virol; 2010 Feb; 84(4):1891-901. PubMed ID: 20007283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
    Yan K; Tan W; Wang H; Wang Y; Zhang X; Li Y; Ruan L
    Viral Immunol; 2009 Feb; 22(1):57-66. PubMed ID: 19210229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
    He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S
    Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
    He Y; Li J; Heck S; Lustigman S; Jiang S
    J Virol; 2006 Jun; 80(12):5757-67. PubMed ID: 16731915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor.
    Chou CF; Shen S; Tan YJ; Fielding BC; Tan TH; Fu J; Xu Q; Lim SG; Hong W
    J Virol Methods; 2005 Jan; 123(1):41-8. PubMed ID: 15582697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus.
    Sheahan T; Rockx B; Donaldson E; Corti D; Baric R
    J Virol; 2008 Sep; 82(17):8721-32. PubMed ID: 18579604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.